Extract from the Register of European Patents

EP About this file: EP4243878

EP4243878 - LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.08.2023
Database last updated on 14.03.2026
FormerThe international publication has been made
Status updated on  21.05.2022
Most recent event   Tooltip27.11.2025New entry: Renewal fee paid 
Applicant(s)For all designated states
Surrozen Operating, Inc.
171 Oyster Point Blvd. Suite 400
South San Francisco, CA 94080 / US
[2023/38]
Inventor(s)01 / LI, Yang
Mountain View, California 94040 / US
02 / ZHANG, Zhengjian
Albany, California 94706 / US
03 / BREZSKI, Randall J.
Alameda, California 94501 / US
04 / PRESTA, Leonard
San Francisco, California 941098 / US
05 / LOPEZ, Thomas
Palo Alto, California 94305 / US
06 / CHEN, Hui
Foster City, California 94404 / US
07 / BARIBAULT, Helene
Redwood City, California 94062 / US
08 / YEH, Wen-Chen
Belmont, California 94003 / US
09 / TU, Shengjiang
Foster City, California 94404 / US
 [2023/38]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[2023/38]
Application number, filing date21893034.516.11.2021
[2023/38]
WO2021US59564
Priority number, dateUS202063114457P16.11.2020         Original published format: US 202063114457 P
US202163182106P30.04.2021         Original published format: US 202163182106 P
US202163248157P24.09.2021         Original published format: US 202163248157 P
[2023/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022104280
Date:19.05.2022
Language:EN
[2022/20]
Type: A1 Application with search report 
No.:EP4243878
Date:20.09.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 19.05.2022 takes the place of the publication of the European patent application.
[2023/38]
Search report(s)International search report - published on:US19.05.2022
(Supplementary) European search report - dispatched on:EP15.04.2025
ClassificationIPC:A61K47/68
[2023/38]
CPC:
C07K16/28 (EP); C07K14/4705 (EP,KR,US); A61P1/16 (KR,US);
C07K16/24 (US); C07K16/2851 (EP,KR); C12N15/62 (EP);
A61K2039/505 (EP,KR); A61K38/00 (US); C07K2317/24 (EP,KR,US);
C07K2317/52 (EP,KR); C07K2317/55 (EP,KR); C07K2317/56 (EP,KR);
C07K2317/565 (EP,US); C07K2319/00 (EP,KR); C07K2319/03 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/38]
TitleGerman:LEBERSPEZIFISCHE WNT-SIGNALVERSTÄRKENDE MOLEKÜLE UND VERWENDUNGEN DAVON[2023/38]
English:LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF[2023/38]
French:MOLÉCULES D'AMÉLIORATION DE SIGNAUX WNT SPÉCIFIQUES DU FOIS ET LEURS UTILISATIONS[2023/38]
Entry into regional phase15.06.2023National basic fee paid 
15.06.2023Search fee paid 
15.06.2023Designation fee(s) paid 
15.06.2023Examination fee paid 
Examination procedure15.06.2023Examination requested  [2023/38]
06.11.2025Amendment by applicant (claims and/or description)
06.11.2025Date on which the examining division has become responsible
Fees paidRenewal fee
24.11.2023Renewal fee patent year 03
26.11.2024Renewal fee patent year 04
26.11.2025Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I] WO2020014271  (SURROZEN INC et al.) [I] 1-3,5-14 * paragraphs [0007] - [0032] - [0082] - [0086] - [0097] , [0249]; sequence 30 *
 [XI] WO2018140821  (SURROZEN INC et al.) [X] 13,14 * paragraphs [0007] - [0029] - [0036] - [0049] - [0091] , [0092] , [0215] - [0222] *[I] 1-3,5-12
International search[X] US2020048324  (ZHANG ZHENGJIAN et al.) [X] 1-4, 39-42 * claim 5, para [0008], [0011], [0013], [0084], [0105], [0117], [0147], [0245], SEQ ID NOs: 72, 86 *
 [A] US2015299324  (HOFER THOMAS et al.) [A] 1-4,39-42 * abstract, para [0106], SEQ ID NO: 68 *
by applicantWO2011130624
 WO2012138453
 WO2013052523
 WO2013151666
 WO2013071047
 WO2013078199
 WO2012045075
 WO2014081507
 WO2014093924
 WO2014164253
 US8278036
 US8691966
 US8835108
 US8748089
   KNIGHTHANKENSON, MATRIX BIOLOGY, vol. 37, 2014, pages 157 - 161
   ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410
   ALTSCHUL ET AL., NUCLEIC ACIDS RES, vol. 25, 1997, pages 3389 - 3402
   TATUSOVAMADDEN, FEMS MICROBIOL LETT, vol. 174, 1999, pages 247 - 250
   "Methods in Enzymology", vol. 266, OXFORD MOLECULAR GROUP, INC., article "Genetics Computing Group (GCG"
   BOLLAG ET AL.: "Computer Methods for Macromolecular Sequence Analysis", 1996, ACADEMIC PRESS, INC.
   METH. MOL. BIOL., vol. 70, 1997, pages 173 - 187
   J. MOL. BIOL., vol. 48, 1970, pages 443 - 453
   SMITHWATERMAN, ADVANCES IN APPLIED MATHEMATICS, vol. 2, 1981, pages 482 - 489
   ALAN R: "Macromolecule Sequencing and Synthesis", 1988, LISS, INC., article "Current Methods in Sequence Comparison and Analysis", pages: 127 - 149
   SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual", 2001, HARBOR LABORATORY PRESS
   "Oligonucleotide Synthesis", 1984
   "Gene Transfer Vectors for Mammalian Cells", 1987
   "Handbook of Experimental Immunology", 1994
   STOCKERTMORELLASHWELL, TARGETED DIAGNOSTICS AND THERAPY, vol. 4, 1991, pages 41 - 64
   YAN ET AL., TUMOR BIOLOGY, vol. 36, 2015, pages 55 - 67
   D'SOUZADEVARAJAN, JOURNAL OF CONTROLLED RELEASE, vol. 203, 2015, pages 126 - 139
   SCATCHARD ET AL., ANN. N. Y. ACAD. SCI., vol. 51, 1949, pages 660
   "Remington's Pharmaceutical Sciences", 1985, MARK PUBLISHING COMPANY
   MCCOY AJGROSSE-KUNSTLEVE RWADAMS PDWINN MDSTORONI LCREAD RJ, J APPL CRYSTALLOGR, vol. 40, 2007, pages 658 - 674
   J. PHARM. SCI., vol. 66, no. 2, 1977
   STAHLWERMUTH: "Handbook of Pharmaceutical Salts: Properties, Selection, and Use", 2002, WILEY-VCH
   BERGE ET AL.: "Pharmaceutical Salts", J. PHARMA SCI., vol. 66, 1977, pages 119
   GOOD ET AL., BIOCHEMISTRY, vol. 5, 1966, pages 467
   "Short Protocols in Molecular Biology", 1999, JOHN WILEY & SONS
   "Viral Vectors", 1995, ACADEMIC PRESS
   "Immunology Methods Manual", 1997, ACADEMIC PRESS
   DOYLEGRIFFITHS: "Cell and Tissue Culture: Laboratory Procedures in Biotechnology", 1998, JOHN WILEY & SONS
   JANDA ET AL., NATURE, vol. 545, 2017, pages 234
   SANHUEZA CABAKSH MMTHUMA BROY MDDUTTA SPREVILLE CCHRUNYK BABEAUMONT KDULLEA RAMMIRATI M, J. AM. CHEM. SOC., vol. 139, 2017, pages 3528 - 3536
   P.D. ADAMSP.V. AFONINEG. BUNKOCZIV.B. CHENI.W. DAVISN. ECHOLSJ.J. HEADDL.W. HUNGG.J. KAPRALR.W. GROSSE-KUNSTLEVE, ACTA CRYST, vol. D66, 2010, pages 486 - 501
   MEIER MBIDER MDMALSHKEVICH VNSPIESS MBURKHARD P, J MOL BIOL, vol. 300, 2012, pages 857 - 865
   SATO, Y.WATANABE, H.KAMEYAMA, H.KOBAYASHI, T.YAMAMOTO, S.TAKEISHI, T.HIRANO, K.OYA, H.NAKATSUKA, H.WATANABE, T.: "Journal Title: Transplantation Proceedings", vol. 36, October 2004, PUBLISHER: ELSEVIER. PUBLICATION, pages: 2359 - 2361
   SLOWIK, VBORUDE, PJAESCHKE, HWOOLBRIGHT, BLEE, WAPTE, U: "Journal Title: Translational Gastroenterology and Hepatology", vol. 4, March 2019, AME PUBLISHING COMPANY, article "Acute Liver Failure Study Group", pages: 2359 - 2361
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.